EE215 Pharmacoeconomic Analysis of Adjuvant Nivolumab for Patients With Resected Esophageal or Gastroesophageal Junction Cancer in Switzerland

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/2ABB811C.svg?ark=w1%2F20260521%2F2ABB811C&value=id)](https://nobleid.org/work/w1/20260521/2ABB811C)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors